ReviewFrontiers in pharmacology2026
Crosstalk between autophagy-dependent ferroptosis and PANoptosis in myocardial and cerebral ischemia-reperfusion injury: mechanisms and therapeutic implications.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Autophagy determines the fate of immune cells by regulating metabolic remodeling and PANoptosis (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemia-reperfusion injury (IRI) represents a critical pathological process contributing to secondary tissue damage in cardiovascular and cerebrovascular diseases. The complexity of the cell death network involved poses substantial challenges for therapeutic intervention. Among emerging forms of regulated cell death, autophagy-dependent ferroptosis and PANoptosis have attracted considerable attention. This review aims to elucidate the potential formation of a highly coordinated cell death network in myocardial and cerebral IRI through the convergence of these two pathways via shared key molecules. By examining their molecular underpinnings, we focus on core regulators such as NLRP3, STING, RIPK, GPX4, and NCOA4, which not only drive their respective pathways but may also facilitate PANoptosome assembly and integrate death signals, thereby mediating signal amplification and crosstalk. Despite inherent differences between cardiac and cerebral tissues, this network may exert synergistic effects during IRI progression by sharing upstream oxidative stress and inflammatory signals. Although current evidence is largely derived from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.